Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2
- 5 Downloads
Purpose of Review
To update the current knowledge concerning sleep complaints and breathing disorders in myotonic dystrophy type 2 (DM2) and to better understand if sleep and breathing symptoms may add a further clinical definition of DM2.
Although DM2 has been poorly evaluated, the most relevant sleep disorders are sleep-disordered breathing (SDB) (37.5–66.7%) and restless legs syndrome (RLS) (50–60%). Excessive daytime somnolence (EDS) is not consistent with SDB, and a large percentage of patients with sleep complaints (58–69%) report pain. In addition, respiratory dysfunctions are reported in 6 to 15% of DM2 patients, albeit few data are available regarding pulmonary restriction, hypoventilation, and non-invasive ventilation (NIV).
SDB, RLS, and pain may contribute to sleep fragmentation and EDS in DM2. In addition, few studies report hypoventilation and pulmonary restriction, although there are no studies at all on NIV, except for limited clinical experiences. These findings suggest performing a careful pulmonary examination and NIV when required. Furthermore, sleep studies and respiratory evaluation should be recommended if OSA or respiratory muscle dysfunctions are suspected. A large polysomnographic study should be performed to clarify the link between sleep disorders, pain, and sleep disruption in DM2.
KeywordsMyotonic dystrophy type 2 Excessive daytime somnolence Sleep Sleep-disordered breathing Hypoventilation Fatigue Pain
Compliance with Ethical Standards
Conflict of Interest
Andrea Romigi reports other from EISAI, personal fees from SANDOZ, personal fees from Fidia Farmaceutici, outside the submitted work. Giuseppe Vitrani received a personal fee from Fidia Farmaceutici outside the submitted work. Enrica Bonanni, Marco Caccamo, Diego Centonze, Michelangelo Maestri, Carmine Nicoletta, Alessandro Sanduzzi, and Gabriele Siciliano each declare no potential conflicts of interest.
Human and Animal Rights
The article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 1992;255:1253–5.Google Scholar
- 4.Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001;293:864–7.Google Scholar
- 7.•• Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2. J Neurol. 2017;264:2472–80 A detailed clinical chacterization of a large cohort of DM2 patients investigating the role of age and gender influencing DM2 phenotype. CrossRefGoogle Scholar
- 12.Romigi A, Albanese M, Placidi F, Izzi F, Liguori C, Marciani MG, et al. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires. Eur J Neurol. 2014;21:929–34.Google Scholar
- 19.Romigi A, Izzi F, Pisani V, Placidi F, Pisani LR, Marciani MG, et al. Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study. Eur J Neurol. 2011;18:1139–45.Google Scholar
- 21.Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, et al. A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci. 2016;43:163–77.Google Scholar
- 24.Romigi A, Placidi F, Albanese M, Izzi F, Liguori C, Mercuri NB, et al. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology. 2014;83:572–3.Google Scholar
- 27.Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, Buckler AJ, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 1992;355:545–6.Google Scholar
- 30.Sansone VA. The dystrophic and nondystrophic myotonias. Continuum (Minneap, Minn). 2016;22:1889–915.Google Scholar
- 31.Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord. 2003;13:813–21.Google Scholar
- 32.Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, et al. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet. 2011;19:776–82.Google Scholar
- 33.•• Vanacore N, Rastelli E, Antonini G, Bianchi MLE, Botta A, Bucci E, et al. An age-standardized prevalence estimate and a sex and age distribution of myotonic dystrophy types 1 and 2 in the Rome Province, Italy. Neuroepidemiology. 2016;46:191–7 The first age-standardized minimun prevalence and sex and age distribution study of both DM1 and DM2 in a large European general population. CrossRefGoogle Scholar
- 36.•• Poussel M, Thil C, Kaminsky P, Mercy M, Gomez E, Chaouat A, et al. Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: evidence for a dysregulation at central level. Neuromuscul Disord. 2015;25:403–8 DM1 patients showed reduced ventilatory response to CO2 independent of lung function impairment and respiratory muscle weakness, suggesting a central cause of CO2 insensitivity. CrossRefGoogle Scholar
- 39.•• Sansone VA, Gagnon C. Participants of the 207th ENMC workshop. 207th ENMC workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27-29 June 2014, Naarden, The Netherlands. Neuromuscul Disord. 2015;25:432–42 A consensus conference regarding chronic respiratory involvement in mytonic dystrophies. The authors reported the sole experience of NIV in DM2. CrossRefGoogle Scholar
- 40.Pincherle A, Patruno V, Raimondi P, Moretti S, Dominese A, Martinelli-Boneschi F, et al. Sleep breathing disorders in 40 Italian patients with Myotonic dystrophy type 1. Neuromuscul Disord. 2012;22:219–24.Google Scholar
- 41.Gagnon C, Heatwole C, Hébert LJ, Hogrel J-Y, Laberge L, Leone M, et al. Report of the third outcome measures in myotonic dystrophy type 1 (OMMYD-3) international workshop Paris, France, June 8, 2015. J Neuromuscul Dis. 2018;5:523–37.Google Scholar
- 42.Bozovic I, Peric S, Pesovic J, Bjelica B, Brkusanin M, Basta I, et al. Myotonic dystrophy type 2 - data from the Serbian registry. J Neuromuscul Dis. 2018;5:461–9.Google Scholar
- 45.American Academy of Sleep Medicine. International classification of sleep disorders. In: 3rd ed. Darien IL, editor. IL: American Academy of SleepMedicine; 2014; 53.Google Scholar
- 51.Ciafaloni E, Mignot E, Sansone V, Hilbert JE, Lin L, Lin X, et al. The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology. 2008;70:226–30.Google Scholar
- 52.•• Bonanni E, Carnicelli L, Crapanzano D, Maestri M, Simoncini C, Baldanzi S, et al. Disruption of sleep-wake continuum in myotonic dystrophy type 1: beyond conventional sleep staging. Neuromuscul Disord. 2018;28:414–21 A polysomnographic study regarding DM1 patients and cyclic alternating pattern analysis. The authors confirmed REM sleep dysregulation, sleep fragmentation, and nonREM alterations as expressed by slower delta power decline. CrossRefGoogle Scholar
- 54.Huang J, Zhang J, Lam SP, Li SX, Ho CKW, Lam V, et al. Amelioration of obstructive sleep apnea in REM sleep behavior disorder: implications for the neuromuscular control of OSA. Sleep. 2011;34:909–15.Google Scholar
- 58.• Rakocevic Stojanovic V, Peric S, Paunic T, Pesovic J, Vujnic M, Peric M, et al. Quality of life in patients with myotonic dystrophy type 2. J Neurol Sci. 2016;365:158–61 Evaluation of the quality of life of DM2 by disease-specific scales, demonstrating that the most severe DM2 had similar low QoL as in DM1. CrossRefGoogle Scholar
- 62.•• Romigi A, Pierantozzi M, Placidi F, Evangelista E, Albanese M, Liguori C, et al. Restless legs syndrome and post polio syndrome: a case-control study. Eur J Neurol. 2015;22:472–8 The first case-control study showing high prevalence of restless legs syndrome in post-polio syndrome. CrossRefGoogle Scholar
- 64.•• van Vliet J, Tieleman AA, Verrips A, Timmerman H, van Dongen RTM, van Engelen BGM, et al. Qualitative and quantitative aspects of pain in patients with myotonic dystrophy type 2. J Pain. 2018;19:920–30 Pain as a key clinical feature of DM2, as demonstrated by widespreadness of hyperalgesia in DM2. CrossRefGoogle Scholar